26Oct
26Oct
Regroup Mass Notification Partners with The Lake Forest Group to Strengthen Higher Ed Safety
Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, and The Lake Forest Group, experts in strategic security consulting, have entered into a new partnership that will provide organizations — especially colleges and universities — the tools necessary to keep their campuses safe. Read more >>
25Oct
Aras and Zuken Blend PLM and EDM
In this move toward design tool integration, Product Lifecycle Management (PLM) software provider Aras Corp. and EDM company Zuken have put together an integrated platform to help design engineers manage cross-discipline product development. The platform brings together electrical and electronic design data from design creation to manufacturing and makes it available to PLM users. The new solution was created to span enterprise processes across the lifecycle, as well as detailed electrical design and manufacturing....
25Oct
The Luminox XCOR 5261 Chronograph wants to send you (and your wrist) to space
Space, the final frontier. These are the voyages of the starship Your Wrist, whose bold 80+ year mission is to help you carry grocery bags and wear watches like the Luminox XCOR 5261 Chronograph. This unique automatic chronograph from a watchmaker most known for brightly luminous and rugged timepieces, is an homage to spaceflight and looks pretty darn cool. Read more >>
22Oct
Drug Resistant Diseases
Don Straus explains how his firm First Light Biosciences is pioneering a way of better diagnosing infections in order to avoid overprescribing antibiotics. Listen now >>
19Oct
Corbus Pharma (CRBP) Receives EC Orphan Designation for Resunab as CF Treatment
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) announced that the European Commission has granted Orphan Designation in the European Union for the Company's novel synthetic oral endocannabinoid-mimetic drug, Resunab, for the treatment of cystic fibrosis ("CF"). Read more >>
16Oct
The New Space Race: XCOR Lynx
See more about XCOR and its Lynx, an airplane-like rocketship that could one day make four flights a day, five days a week. Read more >>
15Oct
Meet XCOR, One Of The Little Guys In The Commercial Spaceflight Race
XCOR’s aim is for daily space flights. Watch this interview with XCOR founder Jeff Greason. Watch now >>
14Oct
Corbus Pharmaceuticals Announces Completion of Phase 2 Study of Resunab for Systemic Sclerosis
Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has completed the Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis ("systemic sclerosis"). Corbus expects to report topline data from this study in the fourth quarter of 2016. Read more >>
14Oct